| PHAR Stock | | | USD 9.27 0.53 6.06% |
This module uses fundamental data of Pharming Group to approximate its Piotroski F score. Pharming Group F Score is determined by combining nine binary scores representing 3 distinct fundamental categories of Pharming Group NV. These three categories are profitability, efficiency, and funding. Some research analysts and sophisticated value traders use Piotroski F Score to find opportunities outside of the conventional market and financial statement analysis.They believe that some of the new information about Pharming Group financial position does not get reflected in the current market share price suggesting a possibility of arbitrage. Check out
Pharming Group Altman Z Score,
Pharming Group Correlation,
Pharming Group Valuation, as well as analyze
Pharming Group Alpha and Beta and
Pharming Group Hype Analysis.
At this time, Pharming Group's
Short and Long Term Debt Total is relatively stable compared to the past year. As of 12/12/2024,
Net Debt is likely to grow to about 115.3
M, while
Long Term Debt is likely to drop slightly above 95.7
M. At this time, Pharming Group's
Payables Turnover is relatively stable compared to the past year. As of 12/12/2024,
Days Payables Outstanding is likely to grow to 328.77, while
PTB Ratio is likely to drop 3.92.
At this time, it appears that Pharming Group's Piotroski F Score is Frail. Although some professional money managers and academia have recently criticized
Piotroski F-Score model, we still consider it an effective method of
predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
3.0
Piotroski F Score - Frail
| Change in Return on Assets | |
| Cash Flow Return on Assets | |
| Current Quality of Earnings (accrual) | |
| Long Term Debt Over Assets Change | Lower Leverage| Focus | |
| Change In Outstending Shares | |
Pharming Group Piotroski F Score Drivers
The critical factor to consider when applying the Piotroski F Score to Pharming Group is to make sure Pharming is not a subject of accounting manipulations and runs a healthy internal audit department. So, if Pharming Group's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if Pharming Group's financial numbers are properly reported.
Pharming Group NV F Score Driver Matrix
One of the toughest challenges investors face today is learning how to quickly synthesize historical
financial statements and information provided by the company, SEC reporting, and various external parties in order to project the various growth rates. Understanding the correlation between Pharming Group's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Pharming Group in a much-optimized way.
Click cells to compare fundamentals
About Pharming Group Piotroski F Score
F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled
Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.
Pharming Group Current Valuation Drivers
We derive many important indicators used in calculating different scores of Pharming Group from analyzing Pharming Group's financial statements. These drivers represent accounts that assess Pharming Group's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Pharming Group's important valuation drivers and their relationship over time.
Pharming Group ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Pharming Group's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Pharming Group's managers, analysts, and investors.
About Pharming Group Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pharming Group NV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pharming Group using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at
the intrinsic value of Pharming Group NV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing
financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our
fundamental analysis page.
Additional Tools for Pharming Stock Analysis
When running Pharming Group's price analysis, check to
measure Pharming Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharming Group is operating at the current time. Most of Pharming Group's value examination focuses on studying past and present price action to
predict the probability of Pharming Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharming Group's price. Additionally, you may evaluate how the addition of Pharming Group to your portfolios can decrease your overall portfolio volatility.